Understanding Enbrel:

Enbrel (etanercept) is a prescription self-injectable biologic medication used to treat several autoimmune inflammatory conditions in adults and children. It is FDA-approved for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis (in adults and children age 4 and older), and juvenile idiopathic arthritis (in children age 2 and older). Enbrel is administered as a weekly subcutaneous injection using a prefilled SureClick autoinjector, prefilled syringe, or the Enbrel Mini cartridge with AutoTouch reusable autoinjector. It can be used alone or in combination with methotrexate.

How It Works:

Autoimmune inflammatory diseases like rheumatoid arthritis, psoriatic arthritis, and psoriasis are driven by an overactive immune system that mistakenly attacks your own body. A key player in this misguided immune attack is a protein called tumor necrosis factor (TNF). In healthy people,
TNF plays a helpful role in fighting infections. But in autoimmune diseases, the immune system produces too much TNF, which triggers a chain reaction of inflammation that damages your joints, skin, and spine.

Enbrel works by acting as a decoy receptor for TNF. Your cells naturally have TNF receptors on their surface — these are the docking stations where TNF binds to trigger inflammation. Enbrel is an engineered protein that mimics these receptors. When you inject Enbrel, the medication circulates through your bloodstream and intercepts TNF molecules before they can reach your cells’ natural receptors. By capturing and neutralizing excess TNF, Enbrel prevents the inflammatory cascade from being triggered — reducing joint swelling, pain, and destruction in arthritis, and clearing the skin plaques in psoriasis. Enbrel does not cure autoimmune disease, but by controlling the inflammation that drives it, it can halt disease progression and prevent permanent damage. You self-inject once weekly using a prefilled autoinjector, typically in the thigh or abdomen.

Form and Use:

Available as a 50 mg/mL prefilled SureClick autoinjector, 50 mg/mL prefilled syringe, 25 mg/0.5 mL prefilled syringe, and Enbrel Mini cartridge for the AutoTouch reusable autoinjector. Self- inject once weekly under the skin in the thigh, abdomen, or upper outer arm. Enbrel must be refrigerated; remove from the fridge 15–30 minutes before injecting to reduce discomfort.

Generic Availability:

As of April 2026, no biosimilar version of Enbrel is commercially available at U.S. pharmacies. Two etanercept biosimilars have been FDA-approved but are not expected to reach the market until approximately 2029 due to ongoing patent litigation. As a biologic medication, Enbrel’s equivalent would be a biosimilar rather than a traditional generic, and the development and approval process for biosimilars is more complex and expensive than for conventional generics. Until a biosimilar reaches the market, the Patient Assistance Program through.AffordMyPrescriptions provides Enbrel at no medication cost for $69.95 per month. Alternative TNF-blocker medications — including some that already have biosimilars available at lower cost — may also be options worth discussing with your rheumatologist or dermatologist.

Warnings:

Enbrel suppresses parts of your immune system and increases your risk of serious infections, including tuberculosis, fungal infections, and bacterial infections. Your doctor should test you for TB before you start Enbrel and monitor you throughout treatment. Tell your doctor immediately if you develop fever, persistent cough, night sweats, or unusual fatigue. Some patients on TNF blockers have developed unusual cancers, including lymphoma. Do not start Enbrel if you have an active infection. Avoid live vaccines while on Enbrel. Tell your doctor about all other medications you take, especially other immunosuppressants.